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The role of the sino-nasal microbiome in CRS remains unclear. We hypothesized that the
bacteria within mucosal-associated biofilms may be different from the more superficial-
lying, free-floating bacteria in the sinuses and that this may impact on the microbiome re-
sults obtained. This study investigates whether there is a significant difference in the micro-
biota of a sinonasal mucosal tissue sample versus a swab sample.
Methods
Cross-sectional study with paired design. Mucosal biopsy and swab samples were obtained
intra-operatively from the ethmoid sinuses of 6 patients with CRS. Extracted DNA was se-
quenced on a Roche-454 sequencer using 16S-rRNA gene targeted primers. Data were an-
alyzed using QIIME 1.8 software package.
Results
At a maximum subsampling depth of 1,100 reads, the mean observed species richness
was 33.3 species (30.6 for swab, versus 36 for mucosa; p > 0.05). There was no significant
difference in phylogenetic and non-phylogenetic alpha diversity metrics (Faith’s PD_Who-
le_Tree and Shannon’s index) between the two sampling methods (p > 0.05). The type of
sample also had no significant effect on phylogenetic and non-phylogenetic beta diversity
metrics (Unifrac and Bray-Curtis; p > 0.05).
Conclusion
We observed no significant difference between the microbiota of mucosal tissue and swab
samples. This suggests that less invasive swab samples are representative of the sinonasal
mucosa microbiome and can be used for future sinonasal microbiome studies.
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Introduction
Recent advances in high-throughput DNA sequencing technology have revolutionized bacterial
detection techniques. Contrary to traditional isolation methods, which are prone to biases inher-
ent in the varying abilities of bacteria to grow in culture, sequencing allows direct examination
of the DNA content in a sample. Based on these DNA readings, we are thus able to infer the bac-
teria contained within. This molecular method is very sensitive and is able to provide a more
complete picture of all the microbes living in a certain environment, what is termed the micro-
biome. Recently there has been increased interest in sinonasal microbiome research, and how
changes in the microbiome could relate to sinus conditions such as chronic rhinosinusitis
(CRS). Recent findings point towards reduced microbial diversity in CRS patients, when com-
pared with healthy controls.[1,2] To the best of our knowledge, almost all 16S rRNA sinonasal
microbiome studies to date have relied upon sampling via swabs[3–5] or via sinus lavage[2,6],
with no studies examining the microbiome of mucosal biopsies. Recent parallel research does
suggest that bacteria existing within the sinus mucosa itself,[7,8] or adherent to the mucosa in
the form of a bacterial biofilm, is associated with the disease state of CRS. [9] Numerous studies
have demonstrated biofilms to be associated with an inflammatory response in the underlying
mucosa,[10–13] and clinical studies suggested that these bacterial forms may predispose to
more severe sinus disease and worse post-operative outcomes.[14,15] Traditionally, particular
bacterial species like Staphylococcus aureus and Pseudomonas aeruginosa have been associated
with these worse outcomes.[16–19]
Knowing this, we hypothesize that mucosal swabs may miss capturing these resistant bacte-
rial forms leading to a mis-representation of the true sinonasal microbiome. To investigate this
we compare the microbiome results of swab samples and mucosal tissue biopsy samples, taken
from the same patients.
Methods
Ethics statement
All participants underwent informed consent, with written consent being obtained prior to en-
rollment. This study was approved by the local institutional review board (The Queen Eliza-
beth Hospital Human Research Ethics Committee), application number: 2011008 (amended).
Study design
This observational cross-sectional study uses a paired design to compare, in the same patients,
two different types of sampling for investigating the sinonasal microbiome—the first type of
sample is a swab, while the second type of sample is a mucosal tissue biopsy. Both types of sam-
ples were obtained intra-operatively from the ethmoid sinuses of patients with CRS.
Study participants
Six CRS patients attending the tertiary Rhinology practice of the senior author (P.J.W.) and
The Queen Elizabeth Hospital (Adelaide, Australia) for primary or revision endoscopic sinus
surgery (ESS) were included in this study. Patients who administered antibiotics or antifungals
in the previous week prior to surgery were excluded from the study. Surgery received was “full-
house” ESS (which includes middle meatal antrostomies, fronto-ethmoidectomies and sphe-
noidectomies). Some patients also had a Draf-III/frontal drillout procedure and/or canine
fossa trephination (CFT) for severe frontal or maxillary disease.
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Sample collection
All samples were collected intra-operatively. Endoscopically-guided swabs were taken from the
anterior ethmoid sinus. We used flocked swabs (Copan Italia S.p.A., Brescia, Italy) to maximize
bacterial yield. After swabbing, mucosal tissue biopsies were taken from the corresponding re-
gion in the anterior ethmoid sinuses using a standard-sized Blakesley forceps (Size 3, cup size
5×15mm; Karl Storz, Tuttlingen, Germany). Samples were always taken from this region, irre-
spective of the presence or absence of pus. To avoid inadvertent contamination, any swabs that
could have come into contact with the nasal vestibule during sampling were discarded. The
swab head was then immediately separated into a sterile container, placed on ice, and then
transported to the laboratory for storage at -80°c.
DNA extraction
Swab heads were thawed, cut into small pieces and then placed in 180 μl of enzymatic lysis
buffer (Qiagen, CA, USA) overnight at room temperature. Bead homogenization was then per-
formed (5mm steel beads agitated for 20 seconds at 15 Hz, followed by 0.1mm glass beads for 5
minutes at 30 Hz). The same extraction procedure was carried out for the tissue biopsy sam-
ples. The remainder of the extraction protocol was performed as per the Qiagen DNeasy
Blood & Tissue Kit instructions (Qiagen, CA, USA). Extracted DNA was stored at -80°c
until sequencing.
PCR amplification of 16S rRNA gene and pyrosequencing
Tag-encoded FLX-Titanium amplicon pyrosequencing for bacterial organisms was performed as
previously described.[20] Briefly, a selective panbacterial 16S-rRNA gene-directed primer set
(“27Fmod” AGRGTTTGATCMTGGCTCAG; and “519Rmodbio”GWATTACCGCGGCK
GCTG) was applied against the 16S rRNA gene for PCR amplification. PCR and pyrosequencing
was performed byMR DNA Lab (Shallowater, TX). A total of 28 cycles of PCR were performed.
DNA was normalized at 7ng/μl average. Sequencing was performed on a Roche 454 sequencer
(F. Hoffmann-La Roche Ltd, Basel, Switzerland). All samples included in this study were se-
quenced in one run.
Bioinformatics pipeline
Raw pyrosequencing data files were then processed using the open-source software pipeline
“Quantitative Insights into Microbial Ecology” (QIIME) version 1.8,[21] utilizing virtual ma-
chines on the Australian National eResearch Collaboration Tools and Resources (NeCTAR) re-
search cloud. Sequences were trimmed of barcodes and primers and sequence quality control
was performed using QIIME's default script settings (sequence length 200–1000 nucleotides;
minimum average qualilty score 25; maximum length of homopolymer runs 6; maximum
number of ambiguous bases 6). Sequences were then denoised using QIIME's built-in denoiser,
set on the Titanium profile.[22] Operational taxonomic units (OTUs) were clustered (open-
reference OTU “picking” against the August 2013 reference Greengenes 16S rRNA database
[23]) at 97% similarity using uclust,[24] and then singleton sequences were removed. Taxo-
nomic assignment of OTUs was then performed using BLAST[25] against the Greengenes 16S
rRNA database.[23] After examining read counts, rarefactions of the OTU table were per-
formed to a chosen maximum subsampling depth of 1100 sequences and rarefaction curves
were plotted. Summary of taxonomic assignments were plotted as bar charts using QIIME. Ob-
served species richness, as well as phylogenetic and non-phylogenetic alpha diversity metrics
(Faith's Phylogenetic Diversity index “PD_Whole_Tree” and Shannon's index, respectively)
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were recorded and compared at the 1100 rarefaction depth. Phylogenetic and non-phylogenet-
ic beta diversity matrices (Weighted/Unweighted UniFrac, and Bray-Curtis, respectively) were
calculated. Three-dimensional Principal Coordinate Analysis (PCoA) plots were generated
using EMPeror software[26] bundled with QIIME. Using the principal coordinates of the
PCoA plots, a Procrustes transformation was performed (over the first three principal compo-
nents) of the swab samples against those of the tissue samples. This was done using the QIIME
script transform_coordinate_matrices.py. Using this script, anm2 value is calculated, and
Monte-Carlo simulations (1000 permutations) were done to calculate a p-value.
Statistical analysis
All statistics were performed using R statistical software[27] (R Foundation for Statistical Com-
puting, Vienna, Austria) through the IPython notebook interface.[28] Statistical significance
was considered at the 0.05 level. Alpha diversity metrics were compared between the two sample
types using Wilcoxon signed rank test. Beta diversity distances within-group were compared to
between-group non-parametrically using a 999-permutations t-test. Testing for the presence of
a significant effect of sample type on beta diversity metrics was also done using permutational
multivariate analysis of variance[29] (PERMANOVA), through the function “adonis” present
in the vegan R package.[30] To accommodate the paired design, the adonis function was em-
ployed using the strata parameter; this allowed the permutations to be done only within the pa-
tient variable, not across. We then investigated statistically significant differential relative
abundance (MRA) of any bacterial species (of more than 1%) between the two groups using
Wilcoxon signed rank tests. Correlation between the taxonomic assignment summaries of the
two groups (Pearson's Correlation coefficient) was calculated non-parametrically using a two-
sided 999 permutations test, using the QIIME script compare_taxa_summaries.py. This script
(in paired mode) compares pairs of samples across two groups (within patient) and additionally
calculates a summarized value for the whole comparison.
Results
Demographic and clinical data
In total, six CRS patients undergoing endoscopic sinus surgery were included in this study.
Two of the patients had CRS without nasal polyposis (CRSsNP) and four had nasal polyposis
(CRSwNP). Five patients had concomitant asthma. Two patients had aspirin sensitivity.
Taxonomic summary
The mean number of sequences per sample was 2865.333 sequences (SD 2805.204). Our final
OTU table contained 1169 unique OTUs (at 97% similarity) in 12 samples (6 tissues, 6 swabs).
Upon taxonomy assignment, these OTUs represented 312 unique bacterial genera across 24
phyla. Fig 1 shows the distribution of bacterial phyla in the studied samples. Only 10 genera,
out of the 312, had a mean relative abundance of more than 1%, and these are listed in Table 1.
Effect of sample type on observed species richness and alpha diversity
Rarefactions were performed to a depth of 1100 reads. At the maximum subsampling depth of
1100 reads, the mean observed species richness was 33.3 species (36 species for mucosal tissue,
versus 30.6 species for swab). Rarefaction curves for richness in all 12 samples plateau at the
maximum depth, (Fig 2A) indicating an adequate sampling procedure. There was no signifi-
cant difference in the observed species richness between both groups (Wilcoxon Signed Rank
test, p = 0.44). There was no significant difference in the phylogenetic and non-phylogenetic
Sinonasal Microbiome Sampling Techniques
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Fig 1. Distribution of bacterial phyla across all samples.
doi:10.1371/journal.pone.0123216.g001
Table 1. Most abundant taxa in our cohort.












g. Corynebacterium 35.00 47.80 22.20 25.6 >0.05 >0.05
g. Staphylococcus 30.20 34.60 25.80 8.8 0.031* >0.05
g. Propionibacterium 3.80 2.80 4.70 1.9 >0.05 >0.05
g. Pseudonocardia 2.70 0.20 5.20 5 >0.05 >0.05
g. Anaerococcus 1.70 2.10 1.20 0.9 >0.05 >0.05
Family Comamonadaceae (genus not
assigned)
1.60 1.10 2.10 1 >0.05 >0.05
Family Xanthomonadaceae (genus not
assigned)
1.40 0.10 2.60 2.5 >0.05 >0.05
g. Peptoniphilus 1.40 1.60 1.10 0.5 >0.05 >0.05
g. Beijerinckia 1.10 0.00 2.30 2.3 >0.05 >0.05
Family Neisseriaceae (genus not
assigned)
1.10 1.80 0.40 1.4 >0.05 >0.05
† Wilcoxon signed rank test between tissue and swab groups
†† FDR = Benjamini-Hochberg’s False Discovery Rate
* = p-value less than 0.05
MRA = Mean Relative Abundance (%)
doi:10.1371/journal.pone.0123216.t001
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alpha diversity metrics (Faith’s PD_Whole_Tree and Shannon’s index) between the two sam-
pling methods (Wilcoxon Signed Rank test, p = 0.44 and p = 0.09, respectively).
Effect of sample type on beta diversity
Beta diversity distance matrices were generated, usingWeighted/unweighted UniFrac and Bray-
Curtis distances between all samples. The mean distances between samples within the same
sample type group (i.e. within-swab, as well as within-tissue) did not differ significantly from
mean distances between samples across sample type groups (i.e. between swab and mucosa).
(Weighted UniFrac, unweighted UniFrac, Bray-Curtis; p> 0.05; Fig 3) This indicates that sam-
ples within each group were as similar to each other as to samples across the two groups. More-
over, the mean Bray-Curtis andWeighted UniFrac within-patient distances were significantly
lower than between-patient distances (p< 0.05; Fig 3), indicating lower diversity and closer
similarity within each patients paired samples (versus between-patient). Similarly, the within-
patient unweighted UniFrac distances were also lower than the between-patient distances but
this was not statistically significant. (Fig 3) We then examined the effect of sample type on the
Weighted and unweighted UniFrac (phylogenetic) and Bray-Curtis (non-phylogenetic) distance
matrices using PERMANOVA, while constraining permutations within the patient variable to
account for the paired design. We found no evidence of significant impact of sample type on the
Unweighted UniFrac distance matrix (pseudo-F-statistic = 0.93, p = 0.35), Weighted UniFrac
Fig 2. Rarefaction plots. (2A) Rarefaction plots of all 12 samples (one curve per sample) showing curves reaching asymptote at the cut-off of 1100 reads.
(2B) Rarefaction curves (number of observed species on Y axis) for mucosal tissue (blue curve) versus swab (red curve). Richness at the 1100 cut-off was
36 for mucosal tissue, versus 30.6 for swab. (p > 0.05). (2C) Rarefaction curves (Faith’s Phylogenetic Diversity “PD_Whole_Tree” on Y axis) for mucosal
tissue (blue curve) versus swab (red curve). (p > 0.05). (2D) Rarefaction curves (Shannon’s index on Y axis) for mucosal tissue (blue curve) versus swab (red
curve).
doi:10.1371/journal.pone.0123216.g002
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distance matrix (pseudo-F-statistic = 1.03, p = 0.06), as well as on the Bray-Curtis distance ma-
trix (PERMANOVA pseudo-F-statistic = 0.63, p = 0.41).
Principal Coordinate Analysis (PCoA) and Procrustes Analysis
We then examined beta diversity distances between samples using Principal Coordinate Analy-
sis (PCoA). The PCoA plots show good clustering of the pair of samples collected from the
same patient, but shows less defined clustering of swab versus tissue samples. (Figs 4 and 5).
Procrustes analysis was then done on these PCoA plots, such that to compare the principal
coordinates of the swab samples to those of the tissue samples. Them2 statistic produced by
the Procrustes analysis is a value that can range from 0 (in this case the matrices are identical/
Fig 3. Boxplots showing distances from Bray-Curtis, unweighted UniFrac, andWeighted UniFrac distance matrices. Boxplots show no significant
difference between within-sampletype and between-sampletype distances, and a statistically significant difference between within-patient and between-
patient Bray-Curtis andWeighted UniFrac distances. Whiskers extend to cover the whole range of values. * = p < 0.05 (two-tailed Student's t-test, computed
through QIIME’s script make_distance_boxplots.py).
doi:10.1371/journal.pone.0123216.g003
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highly similar) to 1 (matrices are completely dissimilar). The values obtained were:m2 = 0.293,
Monte-Carlo p = 0.020 (for Bray-Curtis PCoA) andm2 = 0.368, Monte-Carlo p = 0.055 (for
Weighted UniFrac PCoA). Procrustes plots can be found in Fig 6.
Investigating significant differential abundance of species between both
sampling methods
We then usedWilcoxon ranked sum tests to compare mean relative abundances (MRA) of bac-
terial genera in the two groups. We only found one statistically significant result
Fig 4. PCoA plots (by patient). PCoA plot showing good clustering of pairs of samples originating from the same patient. Points in three-dimensional space
represent samples, each colored according to the patient. Each patient has two samples. (PCoA of Bray-Curtis distances on the left; PCoA of Weighted
UniFrac distances on the right).
doi:10.1371/journal.pone.0123216.g004
Fig 5. PCoA plots (by sample type). PCoA plots showing less defined clustering of samples, each colored according to the sample type (red for swab; blue
for tissue). (PCoA of Bray-Curtis distances on the left; PCoA of Weighted UniFrac distances on the right).
doi:10.1371/journal.pone.0123216.g005
Sinonasal Microbiome Sampling Techniques
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(Staphylococci, 8.8% difference in MRA; 34.6% in swab versus 25.8% in tissue), however this
did not remain significant after correction for multiple comparisons using the Benjamini-
Hochberg False Discovery Rate (FDR). (Table 1) No other genera showed a statistically signifi-
cant differential abundance between the two sampling methods. (p> 0.05) The largest differ-
ence in MRA between swab and tissue was found in Corynebacterium (higher abundance in
swabs, 25.6% difference in MRA; Table 1)
Pearson's correlation coefficient between the two sampling methods
Taxa summaries in both types of sample were compared in each patient in a paired method,
using Pearson's correlation coefficient. This was calculated using the QIIME script compare_
taxa_summaries.py. The summarized overall coefficient calculated by the script was 0.77 [95%
CI:0.75 to 0.78] (p = 0.001), indicating a strong correlation of taxonomic assignment between
both sampling methods. The detailed within patient paired correlation results are found in
Table 2, which shows a strong correlation between all pairs except for one pair of samples
which showed no or weak correlation.
Fig 6. Procrustes plots.Using the principal coordinates of the PCoA plots, Procrustes transformation on (the first three) principal coordinates of the swab
samples over those of the tissue samples was done.
doi:10.1371/journal.pone.0123216.g006
Table 2. Pairwise, within-patient correlations as calculated by the QIIME script compare_taxa_summ-
aries.py.







The table shows signiﬁcant correlations in ﬁve out of the six sample pairs.
doi:10.1371/journal.pone.0123216.t002
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Discussion
In this study, we investigated whether there was a significant difference in microbiome results
between swab and mucosal tissue samples obtained from the same site of the same patients.
We investigated this through alpha diversity, beta diversity, PCoA, as well as the taxonomy as-
signments. Our results suggest a good correlation between swabs and mucosal tissue samples,
with no major significant differences in bacterial composition.
We found that mucosal tissue biopsy samples had higher observed species richness (30.6
species for swab, versus 36 species for mucosa) as well as alpha diversity indices (Faith’s and
Shannon’s indices) (Fig 2B, 2C and 2D). However, this difference in richness and diversity did
not reach statistical significance between the two groups. The plots in Fig 2A show that rarefac-
tion curves have plateaued and reached asymptote. This indicates good sampling at the chosen
cutoff depth of 1100 reads, and that a higher depth of sequencing is unlikely to discover more
unique species (and increased diversity) for the sampled environment. We then explored
whether the type of sample would have an effect on beta diversity metrics (Bray-Curtis and
Weighted and unweighted UniFrac), and this showed no significant effect of sample type on
beta diversity. (Fig 3) PCoA plots suggested a better clustering of samples by patient, rather
than the type of sample. (Figs 4 and 5) Moreover, we calculated a high Pearson’s correlation co-
efficient between the taxa summaries of both sample types (r = 0.77, p = 0.001).
Previous studies showed considerable variability in sinus microbiota between individuals.
We believe comparing the microbiota of tissue biopsy and swab samples obtained from the
same patient controls for this inter-patient variability. Both sample types were taken from the
same sites. This paired comparison design is one of the strengths of this study, as it increases its
statistical power and minimizes the effect of confounding variables.
The alpha and beta diversity metrics (Faith’s PD_Whole_Tree, Shannon’s, Bray-Curtis,
Weighted UniFrac) measured in this study were particularly chosen for the following reasons.
First, these measures include both non-phylogenetic metrics (Shannon’s for alpha diversity and
Bray-Curtis for beta diversity) as well as phylogenetic metrics (Faith’s PD_Whole_Tree for
alpha diversity and UniFrac for beta diversity). Phylogenetic metrics include information about
the evolutionary distance between taxa, since they account for the structure of the phylogenetic
tree. Non-phylogenetic metrics do not account for this information and only depend on taxa
abundance (or prevalence) and evenness. Second, we have also included metrics that account
for the relative abundance of taxa (Bray-Curtis, Weighted UniFrac), contrary to using only met-
rics such as Jaccard’s or unweighted UniFrac that depend on absence/presence (i.e. prevalence)
of taxa, without accounting for their relative abundance. In this way, we could demonstrate that
both methods of sampling (tissue and swab) are not only similar in regards to absence/presence
of taxa, but also in regards to their relative abundance within each sample. Despite mucosal tis-
sue samples having higher richness and within-community (α) diversity, we could not demon-
strate that this was significantly higher than swab samples.
Some analyses in our study approached statistical significance (for example, Shannon’s index
comparison p value was 0.09 andWeighted UniFrac Permanova p = 0.06), which may imply the
presence of a significant difference between swab and tissue samples, especially given the small
number of samples in our cohort. Nevertheless, we believe positive results of all analysis types in
the current study, which includes other metrics (alpha diversity metrics, beta diversity distances,
PCoA plots, Pearson’s correlation), supports a general conclusion of tissue and swab similarity.
This raises the question of power in the realm of microbiota comparison studies, which is a sub-
ject of ongoing research.[31,32] Moreover, what is the clinically-significant “effect size” calculat-
ed out of the commonly used diversity measures, and that would correlate with sinus health
and/or disease? These questions need to be better defined for future research. Future studies
Sinonasal Microbiome Sampling Techniques
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confirming the findings of our study may benefit from including a larger cohort. Another caveat
with our current study design is the possibility that taking the swab samples (first) somehow
perturbed the surface microbiome of the tissue, which was biopsied from the same site after
swabbing (middle meatus/anterior ethmoid region). Although this limitation seems unavoidable
with the current study design, we believe this issue would not cause a significant change to the
tissue specimens, since the tissue biopsied is typically larger than the surface area covered by the
swab head, and thus is not limited only to the thin strip touched by the swab.
Although our rarefaction curves indicate a saturation of diversity at our chosen cut-off rare-
faction depth (Fig 2C and 2D), future studies should investigate using the Illumina sequencing
platform, which allows sequencing at ultra-high depths, with millions of reads generated per
run.[33] The Illumina platform is thus better poised to examine the population belonging to
the “rare biosphere”, and thus the only limitation to accurately characterizing this rare popula-
tion would be sequencing errors or limitations of the bioinformatics analysis such as imperfect
OTU clustering.[34,35] In our study, it appears that the UniFrac metric (which does not take
abundance of the taxa into account, giving abundant and rare taxa equal weight) is less able to
show the within-patient similarity of swab and tissue samples, in contrast to Bray-Curtis or
Weighted UniFrac (Fig 3). This may suggest either a less than perfect ability of swab samples to
accurately characterize the rare biosphere, or is an artefact of the OTU clustering. This is an ad-
ditional reason to confirm the findings of this experiment on the Illumina platform in the fu-
ture. Some sinonasal microbiome studies also used lavage sampling.[2,6] Unfortunately, this
type of sampling was not investigated in our study.
Although the aim of this study is not to describe the CRS sinonasal microbiome, we also re-
port on the taxa discovered (Table 1). Our findings show that Corynebacteria, Staphylococci
and Propionibacteria are the most abundant micro-organisms. (Table 1) These genera were
also reported in previous studies as abundant in the sinuses.[4,36]. Interestingly, out of the 312
bacterial genera assigned in our study, only 10 (about 3%) had a mean relative abundance of
more than 1% (Table 1). This suggests the presence of a “rare biosphere” in the sinuses. This
rare biosphere may constitute then about 97% of all species present in the sinuses. However the
role played by these rare taxa, and whether they contribute significantly to sinus health or dis-
ease, is still unknown; although other studies suggested they have great functional importance
at other sites such as the gut and oral microbiota.[37,38] With this said, the small sample size
and lack of a healthy control group makes it difficult to draw further conclusions on the sinus
microbiome in CRS patients.
Conclusion
In summary, our results suggest that there is no significant difference between mucosal tissue
and swab samples and both methods showed strong correlation. We therefore propose that
swab samples are sufficiently representative of the sinonasal mucosa microbiome and therefore
can be used for future sinonasal microbiome studies. This obviates the need for invasive mucosal
biopsies and also means that sinus microbiome swabs can be obtained from healthy and dis-
eased patients intra-operatively, as well as post-operatively in the clinic. Future studies confirm-
ing these findings should explore: investigating sinus lavage samples, including a higher number
of individuals, and using sequencing platforms that allow ultra-high depths of sequencing.
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